Knight Therapeutics | GUD - Trade Creditors


Knight Therapeutics reported CAD125.76M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Akebia Therapeutics USD 9.42M 1.04M Jun/2026
Alaunos Therapeutics USD 400K 213K Mar/2026
Aurora Cannabis CAD 9.31M 58.72M Mar/2026
Avita Medical AUD 8.96M 1.69M Dec/2025
Canopy Growth CAD 34.82M 14.85M Mar/2026
Cronos Group USD 17.42M 7.14M Jun/2026
Dianthus Therapeutics USD 6.39M 1.12M Jun/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
IQVIA Holdings USD 3.61B 31M Jun/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Moderna USD 167M 6M Jun/2026
Omeros USD 8.84M 4.42M Jun/2025
Organigram Holdings CAD 73.14M 2.06M Mar/2026
Organon & Co USD 983M 31M Mar/2026
Revvity USD 165.74M 3.94M Jun/2026
Tectonic Therapeutic USD 2.55M 1.46M Mar/2026
Tilray USD 114.5M 3.69M Sep/2025
Viatris USD 1.2B 93.9M Mar/2026
Xeris Pharmaceuticals USD 9.34M 2.13M Jun/2026